Search

Displaying results 9701 - 9710 of 10000 in total
  1. Drug

    TAK-901

    go.drugbank.com/drugs/DB12756
    Investigational

    TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.

  2. Drug

    Willow bark

    go.drugbank.com/drugs/DB14691
    Approved

    Categories: Herbs and Natural Products
  3. Drug

    Peptide-T

    go.drugbank.com/drugs/DB19279
    Investigational

    Peptide-T is under investigation in clinical trial NCT00000392 (Phase II Study of the Efficacy of Peptide T in Hiv-positive Individuals With Cognitive Impairment.).

    Categories: Amino Acids, Peptides, and Proteins
  4. Drug

    VGV-1

    go.drugbank.com/drugs/DB05328
    Experimental

    VGV-1 is a potential salvage therapy for treatment of HIV infected people who have failed anti-retroviral therapy.

  5. Drug

    Defoslimod

    go.drugbank.com/drugs/DB20763
    Investigational

    Defoslimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Defoslimod is a immunomodulator, both stimulant/suppressive and stimulant. … Defoslimod is under investigation in clinical trial NCT01800812 (Effects of OM-174 in Adult Patients With Solid Tumors). Defoslimod has a monoisotopic molecular weight of 1148.65 Da.

  6. Drug

    Etentamig

    go.drugbank.com/drugs/DB17268
    Investigational

    TNB-383B is a CD3 and B-cell maturation antigen T-cell engaging bispecific antibody.

  7. Drug

    RP-L301

    go.drugbank.com/drugs/DB17661
    Investigational

    RP-L301 is a lentiviral vector containing the human liver and erythroid pyruvate kinase gene.

  8. Drug

    ASP-2138

    go.drugbank.com/drugs/DB18473
    Investigational

    ASP-2138 is a bispecific antibody directed against CLDN18.2 and T cell receptor complex CD3

  9. Drug

    STP-707

    go.drugbank.com/drugs/DB18499
    Investigational

    STP-707 is a small interfering RNA (siRNA) targeting TGF-Beta1 and COX-2 mRNA.

  10. Drug

    GSK-269962A

    go.drugbank.com/drugs/DB17030
    Experimental

    GSK-269962A is a Rho kinase (ROCK) inhibitor with both ROCK1 and ROCK2 affinity.[A253012]

    Synonyms: Benzamide, n-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1h-imidazo(4,5-c)pyridin-6-yl)oxy)phenyl)-4-(2-(4-morpholinyl)ethoxy)-, N-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1h-imidazo(4,5-c)pyridin-6-yl)oxy)phenyl)-4-(2-(4-morpholinyl)ethoxy)benzamide